Resumen de acción ATR
AptarGroup, Inc. diseña y fabrica una gama de soluciones y servicios de administración de fármacos, dispensación de productos de consumo y ciencia de materiales activos para los mercados farmacéutico, de belleza, cuidado personal, cuidado del hogar y alimentación y bebidas.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Competidores de AptarGroup, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$144.38 |
| 52 Week High | US$148.51 |
| 52 Week Low | US$111.63 |
| Beta | 0.58 |
| 1 Month Change | 0.34% |
| 3 Month Change | 11.16% |
| 1 Year Change | 19.84% |
| 3 Year Change | -6.86% |
| 5 Year Change | 26.68% |
| Change since IPO | 2,861.64% |
Noticias y actualizaciones recientes
Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet
Apr 25
AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet
Mar 28Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet
Apr 25AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet
Mar 28Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Mar 07Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)
Feb 21AptarGroup, Inc. (NYSE:ATR) Shares Could Be 23% Below Their Intrinsic Value Estimate
Feb 08AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward
Jan 26AptarGroup: Exceptional Quality, But Priced For Perfection
Jan 18We Think AptarGroup (NYSE:ATR) Can Stay On Top Of Its Debt
Dec 12If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity
Nov 29AptarGroup: The Market Price Has Run Ahead Of Its Performance
Oct 20Slowing Rates Of Return At AptarGroup (NYSE:ATR) Leave Little Room For Excitement
Sep 22AptarGroup, Inc. (NYSE:ATR) Shares Could Be 25% Below Their Intrinsic Value Estimate
Sep 07AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet
Aug 23Do AptarGroup's (NYSE:ATR) Earnings Warrant Your Attention?
Aug 03AptarGroup: There Are Better Prospects Out There
Jul 29AptarGroup (NYSE:ATR) Will Pay A Larger Dividend Than Last Year At $0.41
Jul 17A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)
Jun 09AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward
May 25AptarGroup (NYSE:ATR) Is Paying Out A Dividend Of $0.38
Apr 24Is AptarGroup (NYSE:ATR) Using Too Much Debt?
Apr 03AptarGroup Non-GAAP EPS of $0.92 beats by $0.13, revenue of $795.91M beats by $20.34M
Feb 16Aptar Pharma launches nasal spray pump
Jan 30AptarGroup: A Solid Business That's Just A Bit Too Pricey
Jan 17AptarGroup realigns two business reporting segments
Dec 13AptarGroup (NYSE:ATR) Seems To Use Debt Quite Sensibly
Dec 12AptarGroup Non-GAAP EPS of $0.95 beats by $0.01, revenue of $836.86M misses by $1.63M
Oct 27AptarGroup declares $0.38 dividend
Oct 13There Are Reasons To Feel Uneasy About AptarGroup's (NYSE:ATR) Returns On Capital
Sep 18Calculating The Fair Value Of AptarGroup, Inc. (NYSE:ATR)
Sep 01AptarGroup: Consider The Bonds
Aug 30Is AptarGroup (NYSE:ATR) A Risky Investment?
Aug 03AptarGroup's (NYSE:ATR) Dividend Will Be $0.38
Jul 19AptarGroup declares $0.38 dividend
Jul 13There Are Reasons To Feel Uneasy About AptarGroup's (NYSE:ATR) Returns On Capital
May 20AptarGroup: There Is A Lot Of Room For Growth
May 04AptarGroup (NYSE:ATR) Seems To Use Debt Quite Sensibly
May 03AptarGroup (NYSE:ATR) Has Affirmed Its Dividend Of US$0.38
Apr 18Estimating The Fair Value Of AptarGroup, Inc. (NYSE:ATR)
Apr 15Should You Be Adding AptarGroup (NYSE:ATR) To Your Watchlist Today?
Mar 19Capital Allocation Trends At AptarGroup (NYSE:ATR) Aren't Ideal
Feb 08Rentabilidad de los accionistas
| ATR | US Packaging | Mercado US | |
|---|---|---|---|
| 7D | 3.0% | 1.7% | -0.7% |
| 1Y | 19.8% | 11.2% | 22.3% |
Rentabilidad vs. Industria: ATR superó al sector US Packaging , que obtuvo un rendimiento del 8.9% el año pasado.
Rentabilidad vs. Mercado: ATR obtuvo unos resultados inferiores a los del mercado US, que fue del 22.2% el año pasado.
Volatilidad de los precios
| ATR volatility | |
|---|---|
| ATR Average Weekly Movement | 2.4% |
| Packaging Industry Average Movement | 4.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: ATR no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ATR (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1992 | 13,800 | Stephan Tanda | www.aptar.com |
AptarGroup, Inc. diseña y fabrica una gama de soluciones y servicios de administración de fármacos, dispensación de productos de consumo y ciencia de materiales activos para los mercados farmacéutico, de belleza, cuidado personal, cuidado del hogar y alimentación y bebidas. La empresa opera a través de los segmentos Aptar Pharma, Aptar Beauty y Aptar Closures. También suministra bombas para tratamientos nasales contra la alergia; y válvulas para inhaladores dosificadores para dolencias respiratorias, como el asma y las enfermedades pulmonares obstructivas crónicas; elastómero para componentes de envases primarios inyectables; y soluciones de ciencia de materiales activos.
Resumen de fundamentos de AptarGroup, Inc.
| Estadísticas fundamentales de ATR | |
|---|---|
| Capitalización bursátil | US$9.57b |
| Beneficios(TTM) | US$312.83m |
| Ingresos (TTM) | US$3.54b |
30.6x
Ratio precio-beneficio (PE)2.7x
Ratio precio-ventas (PS)¿Está ATR sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ATR | |
|---|---|
| Ingresos | US$3.54b |
| Coste de los ingresos | US$2.25b |
| Beneficio bruto | US$1.29b |
| Otros gastos | US$980.62m |
| Beneficios | US$312.83m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Jul 25, 2024
| Beneficios por acción (BPA) | 4.72 |
| Margen bruto | 36.51% |
| Margen de beneficio neto | 8.83% |
| Ratio deuda/patrimonio | 46.9% |
¿Cómo se ha desempeñado ATR a largo plazo?
Ver rendimiento histórico y comparativa